Medigene ( (DE:MDG1)) has issued an update. Medigene AG has announced the execution of the first tranche of a Standby Equity ...

Medigene has said it will cut 40% of its workforce and delay the start of clinical trials of its lead asset as it re-jigs its pipeline of T-cell receptor (TCR) therapies for cancer. For the time ...

The Singapore-based firm has been seeking to sell Everlife Holdings for over $500 million since the end of last year, in the wake of several attractively valued deals in the healthcare space.

SINGAPORE: Global investment firm Hillhouse is emerging as one of the final few bidders for Everlife Holdings in a deal that could value the Asian healthcare services company at up to US$1bil ...